EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Iron( ii )-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies

Seth Asamoah, Martin Pravda, Jana Matonohová, Tereza Bártová, Eva Šnejdrová, Sebastian Spiegel, Andrew Chan, Vincent Pernet, Vladimír Velebný

Journal of Materials Chemistry B · 2025

DOI: 10.1039/d4tb02606c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Seth Asamoah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, 500 03 Hradec Králové 3, Czech Republ…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Monophenol Monooxygenase, Hydrogels, Iron. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosinase is a common crosslinker used in the formation of in situ hydrogels, often resulting in significantly longer gelation times.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidMonophenol MonooxygenaseHydrogelsIronHumansDelayed-Action PreparationsDrug LiberationCross-Linking ReagentsHydrogen-Ion Concentration

Substanzen

Hyaluronic AcidMonophenol MonooxygenaseHydrogelsIronDelayed-Action PreparationsCross-Linking Reagents

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203/8, 500 03 Hradec Králové 3, Czech Republic.
  • Contipro a.s., Dolní Dobrouč 401, 56102, Dolní Dobrouč, Czech Republic.
  • Department of Neurology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Experimental Neurology Center (ZEN), Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, 3010 Bern, Switzerland.

Förderung

  • Horizon 2020 Framework Programme

Zitieren

APA

Asamoah, S., Pravda, M., Matonohová, J., Bártová, T., Šnejdrová, E., Spiegel, S., Chan, A., Pernet, V., & Velebný, V. (2025). Iron( ii )-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb02606c

Vancouver

Asamoah S, Pravda M, Matonohová J, Bártová T, Šnejdrová E, Spiegel S, et al. Iron( ii )-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies. Journal of Materials Chemistry B. 2025. doi:10.1039/d4tb02606c

BibTeX
@article{Asamoah2025,
  author = {Asamoah, Seth and Pravda, Martin and Matonohová, Jana and Bártová, Tereza and Šnejdrová, Eva and Spiegel, Sebastian and Chan, Andrew and Pernet, Vincent and Velebný, Vladimír},
  title = {Iron( ii )-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies},
  journal = {Journal of Materials Chemistry B},
  year = {2025},
  doi = {10.1039/d4tb02606c}
}
Kostenlos starten →